Cargando…

Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials

BACKGROUND: Contrast-induced nephropathy (CIN) is one of the common causes of acute renal insufficiency after contrast procedures. Whether intravenous N-acetylcysteine (NAC) is beneficial for the prevention of contrast-induced nephropathy is uncertain. In this meta-analysis of randomized controlled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Zikai, Fu, Qiang, Cao, Longxing, Jin, Wen, Cheng, LingLing, Li, Zhiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559541/ https://www.ncbi.nlm.nih.gov/pubmed/23383076 http://dx.doi.org/10.1371/journal.pone.0055124

Ejemplares similares

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Richter, Sara K., et al.
Publicado: (2015)

Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Arabmomeni, Morteza, et al.
Publicado: (2015)

N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review
por: Jo, Sang-Ho
Publicado: (2011)

Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy – a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial
por: Biernacka-Fiałkowska, Barbara, et al.
Publicado: (2018)

Effectiveness of N‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Xu, Renfan, et al.
Publicado: (2016)

Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy
por: Pezeshgi, Aiyoub, et al.
Publicado: (2015)

Association of N-acetylcysteine use with contrast-induced nephropathy: an umbrella review of meta-analyses of randomized clinical trials
por: Zhu, Rong, et al.
Publicado: (2023)

Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy
por: Khaledifar, Arsalan, et al.
Publicado: (2015)

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Publicado: (2009)

N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study
por: Poletti, Pierre-Alexandre, et al.
Publicado: (2013)

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency
por: Dósa, Edit, et al.
Publicado: (2017)

Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis
por: Bagshaw, Sean M, et al.
Publicado: (2004)

Comparison of Oral and Intravenous N-acetyl Cysteine in Preventing Contrast Nephropathy
por: Khatami, Mohammad Reza, et al.
Publicado: (2020)

Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis
por: Li, Jing-Xiu, et al.
Publicado: (2017)

N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients—focus on the antioxidant and anti-inflammatory properties
por: Cepaityte, Dainora, et al.
Publicado: (2023)

Do Intravenous N-Acetylcysteine and Sodium Bicarbonate Prevent High Osmolal Contrast-Induced Acute Kidney Injury? A Randomized Controlled Trial
por: Inda-Filho, Antonio Jose, et al.
Publicado: (2014)

Effect of N-acetyl cysteine in prevention of contrast nephropathy on patients under intravenous pyelography and contrast CT
por: Momeni, Ali, et al.
Publicado: (2012)

Expression of neutrophil gelatinase-associated lipocalin in low osmolar contrast-induced nephropathy in rats and the effect of N-acetylcysteine
por: Li, Wen-Hua, et al.
Publicado: (2016)

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study
por: Palli, Eleni, et al.
Publicado: (2017)

N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial
por: Amini, Manouchehr, et al.
Publicado: (2009)

Prophylaxis of contrast-induced nephropathy in patients with impaired renal function: double-blind comparison of acetylcysteine, theophylline, acetylcysteine + theophylline and placebo
por: Huber, W, et al.
Publicado: (2005)

The use of N-acetylcysteine in the prevention of hangover: a randomized trial
por: Coppersmith, Veronica, et al.
Publicado: (2021)

Fatal myocardial infarction associated with intravenous N-acetylcysteine error
por: Elms, Andrew R, et al.
Publicado: (2011)

N-acetylcysteine ameliorates contrast-induced kidney injury in rats with unilateral hydronephrosis
por: Xia, Qiang, et al.
Publicado: (2018)

Acute Chloroform Ingestion Successfully Treated with Intravenously Administered N-acetylcysteine
por: Dell’Aglio, Damon M., et al.
Publicado: (2010)

Evaluation of the children with acute acetaminophen overdose and intravenous N-acetylcysteine treatment
por: Yesil, Yakup, et al.
Publicado: (2018)

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity
por: Gonzales, Denise A, et al.
Publicado: (2007)

Effects of Remote Ischemic Pre-Conditioning to Prevent Contrast-Induced Nephropathy after Intravenous Contrast Medium Injection: A Randomized Controlled Trial
por: Belabbas, Dihia, et al.
Publicado: (2020)

Pentoxifylline for the prevention of contrast-induced nephropathy: systematic review and meta-analysis of randomised controlled trials
por: Wei, Ling, et al.
Publicado: (2021)

Author Correction: The use of N-acetylcysteine in the prevention of hangover: a randomized trial
por: Coppersmith, Veronica, et al.
Publicado: (2021)

Cephazolin-Induced Toxic Epidermal Necrolysis Treated with Intravenous Immunoglobulin and N-Acetylcysteine
por: Saavedra, Carlos, et al.
Publicado: (2012)

Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine
por: Ibrahim, Homam, et al.
Publicado: (2020)

Response to Intravenous N-Acetylcysteine Supplementation in Critically Ill Patients with COVID-19
por: Gamarra-Morales, Yenifer, et al.
Publicado: (2023)

Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast‐Induced Nephropathy: A Failure of Academic Clinical Science
por: Sandilands, Euan A., et al.
Publicado: (2022)

Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT
por: Choi, Heejung, et al.
Publicado: (2012)

N-Acetylcysteine for Cardiac Protection During Coronary Artery Reperfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Khan, Sher Ali, et al.
Publicado: (2021)

Effectiveness of intravenous infusion of N-acetylcysteine in cirrhotic patients undergoing major abdominal surgeries
por: Ibrahim, Eman Sayed, et al.
Publicado: (2015)

Intravenous N-acetylcysteine in severe cutaneous drug reaction treatment: A case series
por: Hasan, Md Jahidul, et al.
Publicado: (2020)

Efficacy of alprostadil for preventing of contrast-induced nephropathy: A meta-analysis
por: Zhang, Jing-Zhan, et al.
Publicado: (2017)

A Network Meta-Analysis on Randomized Trials Focusing on the Preventive Effect of Statins on Contrast-Induced Nephropathy
por: Peruzzi, Mariangela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sdfgtqohl07dib6di0dicm53lb